Graffinity Pharmaceuticals GmbH announced that it has entered into its second drug discovery collaboration with Pfizer, Inc. Through the collaboration, Graffinity will provide Pfizer with access to …

Life scientists are highly engaged users of a variety of social media, according to preliminary results of a worldwide study of more than 1,500 scientists released today by BioInformatics, LLC. The …

NextGen Sciences has announced the commencement of its collaboration with The Harvard Institute of Proteomics. The collaboration, which marks the start of NextGen Sciences’ Center of Excellence …

Galapagos NV and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the non-profit affiliate of the Cystic Fibrosis Foundation, announced a new collaboration aimed at discovering new treatments …

Bavarian Nordic reports the successful completion of a large, placebo-controlled Phase II trial in 745 healthy subjects who received either one or two doses of IMVAMUNE® third-generation smallpox …

These last two days have been the easiest this year to predict. Its as if the market is reading our commentary…

Today was obviously a fantastic day for the bulls. And Im not embarrassed in the least, because I totally saw this coming and was very vocal about it…

Follow up on our Small Cap Breakout. Follow along as we monitor the real time action of a monster breakout move…

Scientists can only develop new cancer drugs or search for cures by testing their theories on the real thing. Traditionally, they’ve done so by culturing cancer cells on petri dishes or plastic …

Gendux Molecular Limited announced that its Marketing Authorization Application (MAA) for ADVEXIN® (”contusugene ladenovec” ) has been accepted for technical review by the European medicines …